|
WO2020223232A1
(en)
|
2019-04-29 |
2020-11-05 |
The Trustees Of The University Of Pennsylvania |
Novel aav capsids and compositions containing same
|
|
JP7715640B2
(ja)
|
2019-05-03 |
2025-07-30 |
ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア |
異染性白質ジストロフィーの治療に有用な組成物
|
|
BR112022011916A2
(pt)
|
2019-12-19 |
2022-09-06 |
Univ Pennsylvania |
Composições para tratar a ataxia de friedreich
|
|
CA3180222A1
(en)
|
2020-04-15 |
2021-10-21 |
Voyager Therapeutics, Inc. |
Tau binding compounds
|
|
IL298138A
(en)
*
|
2020-05-12 |
2023-01-01 |
Univ Pennsylvania |
Compositions for drg-specific reduction of transgene expression
|
|
US12630842B2
(en)
|
2020-05-13 |
2026-05-19 |
Voyager Therapeutics, Inc. |
Redirection of tropism of AAV capsids
|
|
WO2021247995A2
(en)
|
2020-06-04 |
2021-12-09 |
Voyager Therapeutics, Inc. |
Compositions and methods of treating neuropathic pain
|
|
CA3183153A1
(en)
|
2020-06-17 |
2021-12-23 |
Christian HINDERER |
Compositions and methods for treatment of gene therapy patients
|
|
WO2022015715A1
(en)
|
2020-07-13 |
2022-01-20 |
The Trustees Of The University Of Pennsylvania |
Compositions useful for treatment of charcot-marie-tooth disease
|
|
US20230285596A1
(en)
|
2020-07-27 |
2023-09-14 |
Voyager Therapeutics, Inc |
Compositions and methods for the treatment of niemann-pick type c1 disease
|
|
BR112023001456A2
(pt)
|
2020-07-27 |
2023-04-11 |
Voyager Therapeutics Inc |
Composições e métodos para o tratamento de distúrbios neurológicos relacionados à deficiência de beta glicosilceramidase
|
|
AU2021356684A1
(en)
*
|
2020-10-09 |
2023-05-11 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for treatment of fabry disease
|
|
WO2022082109A1
(en)
|
2020-10-18 |
2022-04-21 |
The Trustees Of The University Of Pennsylvania |
Improved adeno-associated virus (aav) vector and uses therefor
|
|
WO2022094078A1
(en)
|
2020-10-28 |
2022-05-05 |
The Trustees Of The University Of Pennsylvania |
Compositions useful in treatment of rett syndrome
|
|
WO2022119890A1
(en)
|
2020-12-01 |
2022-06-09 |
The Trustees Of The University Of Pennsylvania |
Compositions and uses thereof for treatment of angelman syndrome
|
|
EP4274592A4
(en)
*
|
2021-01-11 |
2025-03-19 |
The Trustees of The University of Pennsylvania |
COMPOSITIONS FOR THE TREATMENT OF FRIEDREICH'S ATAXIA
|
|
WO2022187548A1
(en)
|
2021-03-03 |
2022-09-09 |
Voyager Therapeutics, Inc. |
Controlled expression of viral proteins
|
|
US20240175050A1
(en)
*
|
2021-03-19 |
2024-05-30 |
Mayo Foundation For Medical Education And Research |
Methods and materials for treating propionic acidemia
|
|
EP4323531A1
(en)
|
2021-04-12 |
2024-02-21 |
Affinia Therapeutics Inc. |
Recombinant aav for treatment of neural disease
|
|
WO2023113806A1
(en)
|
2021-12-16 |
2023-06-22 |
Affinia Therapeutics, Inc. |
Recombinant aav for treatment of neural disease
|
|
AU2022262771A1
(en)
|
2021-04-23 |
2023-11-02 |
The Trustees Of The University Of Pennsylvania |
Novel compositions with brain-specific targeting motifs and compositions containing same
|
|
TW202309066A
(zh)
|
2021-04-27 |
2023-03-01 |
賓州大學委員會 |
衍生自豬的腺相關病毒衣殼及其用途
|
|
CN118043468A
(zh)
*
|
2021-06-11 |
2024-05-14 |
分贝治疗公司 |
用于内耳中的细胞类型特异性基因表达的组合物和方法
|
|
WO2023044483A2
(en)
|
2021-09-20 |
2023-03-23 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of her2 positive cancer
|
|
US20240384298A1
(en)
|
2021-10-02 |
2024-11-21 |
The Trustees Of The University Of Pennsylvania |
Novel aav capsids and compositions containing same
|
|
KR20240100490A
(ko)
*
|
2021-10-18 |
2024-07-01 |
더 트러스티스 오브 더 유니버시티 오브 펜실베니아 |
Cdkl5 결핍 장애(cdd)의 치료에 유용한 조성물
|
|
AU2022388800A1
(en)
*
|
2021-11-12 |
2024-06-27 |
The Trustees Of The University Of Pennsylvania |
Gene therapy for treatment of mucopolysaccharidosis iiia
|
|
WO2023087019A2
(en)
*
|
2021-11-15 |
2023-05-19 |
The Trustees Of The University Of Pennsylvania |
Compositions for drg-specific reduction of transgene expression
|
|
EP4433169A1
(en)
|
2021-11-17 |
2024-09-25 |
Voyager Therapeutics, Inc. |
Aav capsid variants and uses thereof
|
|
WO2023092004A1
(en)
|
2021-11-17 |
2023-05-25 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of tau-related disorders
|
|
US20250049955A1
(en)
|
2021-11-17 |
2025-02-13 |
Voyager Therapeutics, Inc. |
Compositons and methods for the treatment of neurological disorders related to glucosylceramidase beta deficiency
|
|
TW202340467A
(zh)
|
2022-01-10 |
2023-10-16 |
賓州大學委員會 |
有用於治療c9orf72介導之病症之組成物及方法
|
|
US20250346920A1
(en)
|
2022-01-25 |
2025-11-13 |
Voyager Therapeutics, Inc. |
Baculovirus expression system
|
|
JP2025507338A
(ja)
|
2022-02-08 |
2025-03-18 |
ボイジャー セラピューティクス インコーポレイテッド |
Aavカプシドバリアント及びその使用
|
|
CA3247109A1
(en)
|
2022-04-06 |
2023-10-12 |
The Trustees Of The University Of Pennsylvania |
Compositions and treatment methods for metastatic breast cancer that is human epidermal growth factor receptor 2 positive and other cancers
|
|
US20250250326A1
(en)
|
2022-04-06 |
2025-08-07 |
The Trustees Of The University Of Pennsylvania |
Passive immunization with anti-aav neutralizing antibodies to prevent off-target transduction of intrathecally delivered aav vectors
|
|
WO2023220695A2
(en)
|
2022-05-13 |
2023-11-16 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of her2 positive cancer
|
|
EP4532515A1
(en)
|
2022-06-02 |
2025-04-09 |
Voyager Therapeutics, Inc. |
Aav capsid variants and uses thereof
|
|
WO2023240236A1
(en)
|
2022-06-10 |
2023-12-14 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of spinal muscular atrophy related disorders
|
|
US20250243263A1
(en)
|
2022-06-22 |
2025-07-31 |
Voyager Therapeutics, Inc. |
Tau binding compounds
|
|
WO2024006741A1
(en)
|
2022-06-28 |
2024-01-04 |
Voyager Therapeutics, Inc. |
Aav capsid variants and uses thereof
|
|
WO2024011112A1
(en)
|
2022-07-06 |
2024-01-11 |
Voyager Therapeutics, Inc. |
Aav capsid variants and uses thereof
|
|
US20260000790A1
(en)
*
|
2022-07-08 |
2026-01-01 |
Ospedale San Raffaele S.R.L. |
Transgene cassettes
|
|
CA3263767A1
(en)
|
2022-08-03 |
2024-02-08 |
Voyager Therapeutics, Inc. |
COMPOSITIONS AND PROCESSES ALLOWING CROSSING THE BLOOD-BRAIN BARRIER
|
|
JP2025535203A
(ja)
|
2022-09-15 |
2025-10-23 |
ボイジャー セラピューティクス インコーポレイテッド |
タウ結合化合物
|
|
JP2025534229A
(ja)
*
|
2022-09-26 |
2025-10-15 |
エンコーデド セラピューティクス,インク. |
後根神経節及び/又は肝臓における遺伝子発現を脱標的化するための要素
|
|
WO2024130070A2
(en)
|
2022-12-17 |
2024-06-20 |
The Trustees Of The University Of Pennsylvania |
Recombinant aav capsids with cardiac- and skeletal muscle- specific targeting motifs and uses thereof
|
|
EP4634394A2
(en)
|
2022-12-17 |
2025-10-22 |
The Trustees of The University of Pennsylvania |
Recombinant aav mutant vectors with cardiac and skeletal muscle-specific targeting motifs and compositions containing same
|
|
WO2024145474A2
(en)
|
2022-12-29 |
2024-07-04 |
Voyager Therapeutics, Inc. |
Compositions and methods for regulating mapt
|
|
AU2023427408A1
(en)
|
2023-02-02 |
2025-09-04 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of neurological disorders related to glucosylceramidase beta deficiency
|
|
WO2024226761A2
(en)
|
2023-04-26 |
2024-10-31 |
Voyager Therapeutics, Inc. |
Compositions and methods for treating amyotrophic lateral sclerosis
|
|
EP4705324A1
(en)
|
2023-05-02 |
2026-03-11 |
Voyager Therapeutics, Inc. |
Compositions and methods for regulating mapt
|
|
IL324036A
(en)
|
2023-05-03 |
2025-12-01 |
Voyager Therapeutics Inc |
Compositions and methods for the treatment of disorders related to glucosylceramidase beta 1 deficiency
|
|
WO2024229389A1
(en)
|
2023-05-03 |
2024-11-07 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of tau-related disorders
|
|
JP2026515970A
(ja)
|
2023-05-04 |
2026-05-19 |
ボイジャー セラピューティクス インコーポレイテッド |
Aavカプシドバリアント及びその使用
|
|
EP4711461A1
(en)
*
|
2023-05-12 |
2026-03-18 |
Genecombio Ltd. |
Viral vector carrying smn gene expression cassette and use thereof
|
|
WO2025007046A1
(en)
|
2023-06-29 |
2025-01-02 |
The Trustees Of The University Of Pennsylvania |
Mutant aav with central nervous system targeting motifs and compositions containing same
|
|
IL326390A
(en)
|
2023-08-10 |
2026-04-01 |
Univ Pennsylvania |
Compositions and methods for treatment of spinal muscular atrophy
|
|
WO2025038805A1
(en)
|
2023-08-16 |
2025-02-20 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of disorders related to glucosylceramidase beta 1 deficiency
|
|
KR20260114566A
(ko)
|
2023-11-14 |
2026-07-22 |
더 트러스티스 오브 더 유니버시티 오브 펜실베니아 |
심근 및 골격근-특이적 표적화 모티프를 갖는 조성물 및 이의 용도
|
|
WO2025122530A1
(en)
|
2023-12-05 |
2025-06-12 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of disorders related to glucosylceramidase beta 1 deficiency
|
|
WO2025122644A1
(en)
|
2023-12-05 |
2025-06-12 |
Voyager Therapeutics, Inc. |
Compositions and methods for regulating mapt
|
|
WO2025122634A1
(en)
|
2023-12-05 |
2025-06-12 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of tau-related disorders
|
|
WO2025129157A1
(en)
|
2023-12-15 |
2025-06-19 |
The Trustees Of The University Of Pennsylvania |
Gene therapy for treatment of canavan disease
|
|
WO2025147436A1
(en)
|
2024-01-03 |
2025-07-10 |
Voyager Therapeutics, Inc. |
Aav capsid variants and uses thereof
|
|
WO2025217023A1
(en)
*
|
2024-04-08 |
2025-10-16 |
The Trustees Of The University Of Pennsylvania |
Gene therapy for gangliosidosis type 2 (gm2)
|
|
WO2025235734A2
(en)
|
2024-05-09 |
2025-11-13 |
Voyager Therapeutics, Inc. |
Aav capsid variants and uses thereof
|
|
WO2026010722A1
(en)
|
2024-07-03 |
2026-01-08 |
Voyager Therapeutics, Inc. |
Compositions and methods for regulating mapt
|
|
WO2026028089A1
(en)
|
2024-07-29 |
2026-02-05 |
Novartis Ag |
Compositions and methods for the treatment of lysosomal acid lipase deficiency (lal-d)
|
|
WO2026101977A1
(en)
|
2024-11-06 |
2026-05-15 |
Voyager Therapeutics, Inc. |
Compositions and methods for regulating mapt
|
|
WO2026102093A1
(en)
|
2024-11-07 |
2026-05-15 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of tau-related disorders
|
|
WO2026151888A1
(en)
|
2025-01-08 |
2026-07-16 |
The Trustees Of The University Of Pennsylvania |
Compositions for treating friedreich's ataxia
|